Iqvia Holdings Inc (N:IQV)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for IQV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 26/20 Mar 24/20 Evanisko Michael J Indirect Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 6,600  
Mar 26/20 Mar 24/20 Evanisko Michael J Indirect Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,600 $21.20
Mar 5/20 Mar 3/20 Staub W Richard Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -259 $141.36
Feb 25/20 Feb 21/20 Knightly Kevin C Direct Ownership Common Stock S - Open market or private sale -2,191 $163.43
Feb 20/20 Feb 19/20 Knightly Kevin C Direct Ownership Common Stock S - Open market or private sale -5,688 $165.09
Feb 21/20 Feb 19/20 Connaughton John Direct Ownership Common Stock G - Gift -5,764  
Feb 21/20 Feb 19/20 Connaughton John Indirect Ownership Common Stock J - Other transaction -68,228  
Feb 20/20 Feb 18/20 Staub W Richard Direct Ownership Stock Appreciation Right M - Exercise or conversion exempt under rule 16b-3 -18,224  
Feb 20/20 Feb 18/20 Staub W Richard Direct Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -8,674 $165.42
Feb 20/20 Feb 18/20 Staub W Richard Direct Ownership Common Stock S - Open market or private sale -14,550 $163.77
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for IQV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 26/20 Mar 24/20 Evanisko Michael J Indirect Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 6,600  
Mar 26/20 Mar 24/20 Evanisko Michael J Indirect Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,600 $21.20
Mar 5/20 Mar 3/20 Staub W Richard Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -259 $141.36
Feb 25/20 Feb 21/20 Knightly Kevin C Direct Ownership Common Stock S - Open market or private sale -2,191 $163.43
Feb 21/20 Feb 19/20 Connaughton John Direct Ownership Common Stock G - Gift -5,764  
Feb 21/20 Feb 19/20 Connaughton John Indirect Ownership Common Stock J - Other transaction -68,228  
Feb 20/20 Feb 18/20 Staub W Richard Direct Ownership Stock Appreciation Right M - Exercise or conversion exempt under rule 16b-3 -18,224  
Feb 20/20 Feb 18/20 Staub W Richard Direct Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -8,674 $165.42
Feb 20/20 Feb 18/20 Staub W Richard Direct Ownership Common Stock S - Open market or private sale -14,550 $163.77
Feb 20/20 Feb 18/20 Staub W Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 18,224 $78.21
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $IQV

Competitors

Competitors with Recent Insider Filings
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)
Precigen (OQ:PGEN)